Showing content from https://pubmed.ncbi.nlm.nih.gov/38400188/ below:
Genital and Oral HPV Geno-Prevalence Measured through Urine and Saliva Samples in Young Adults in Italy
doi: 10.3390/vaccines12020205. Genital and Oral HPV Geno-Prevalence Measured through Urine and Saliva Samples in Young Adults in Italy Silvia Angelillo 2 , Aida Bianco 3 , Gabriella Di Giuseppe 1 , Valeria Di Onofrio 4 , Francesca Licata 2 , Giorgio Liguori 5 , Carmelo Giuseppe Angelo Nobile 6 , Maria Pavia 1 , Concetta Paola Pelullo 5 , Federica Zito Marino 7 , Italo Francesco Angelillo 1
Affiliations
Affiliations
- 1 Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
- 2 Department of Health Sciences, University "Magna Græcia" of Catanzaro, 88100 Catanzaro, Italy.
- 3 Department of Medical and Surgical Sciences, University "Magna Græcia" of Catanzaro, 88100 Catanzaro, Italy.
- 4 Department of Sciences and Technologies, University of Naples "Parthenope", 80143 Naples, Italy.
- 5 Department of Medical, Movement and Wellbeing Sciences, University of Naples "Parthenope", 80133 Naples, Italy.
- 6 Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Cosenza, Italy.
- 7 Department of Mental and Physical Health and Preventive Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
Item in Clipboard
Genital and Oral HPV Geno-Prevalence Measured through Urine and Saliva Samples in Young Adults in Italy
Francesco Napolitano et al. Vaccines (Basel). 2024.
doi: 10.3390/vaccines12020205. Authors Francesco Napolitano 1 , Silvia Angelillo 2 , Aida Bianco 3 , Gabriella Di Giuseppe 1 , Valeria Di Onofrio 4 , Francesca Licata 2 , Giorgio Liguori 5 , Carmelo Giuseppe Angelo Nobile 6 , Maria Pavia 1 , Concetta Paola Pelullo 5 , Federica Zito Marino 7 , Italo Francesco Angelillo 1 Affiliations
- 1 Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
- 2 Department of Health Sciences, University "Magna Græcia" of Catanzaro, 88100 Catanzaro, Italy.
- 3 Department of Medical and Surgical Sciences, University "Magna Græcia" of Catanzaro, 88100 Catanzaro, Italy.
- 4 Department of Sciences and Technologies, University of Naples "Parthenope", 80143 Naples, Italy.
- 5 Department of Medical, Movement and Wellbeing Sciences, University of Naples "Parthenope", 80133 Naples, Italy.
- 6 Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Cosenza, Italy.
- 7 Department of Mental and Physical Health and Preventive Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
Item in Clipboard
Abstract
Background: The aims of the study were to determine, in the urine and oral samples of young adults, the genotype-specific prevalence of Human Papilloma Virus (HPV) infection, the HPV DNA type-specific prevalence in unvaccinated and vaccinated individuals, and the determinants of HPV infection.
Methods: Selected participants were asked to fill in a self-administered questionnaire and to self-collect urine and saliva samples.
Results: Among the 1002 participants, 81 (8.1%) resulted positive for HPV DNA. The most common low-risk genotype was HPV 42 (2.2%), followed by HPV 43 (0.8%), and 40 (0.5%). The HPV 51 was the most common high-risk genotype (1.5%) followed by HPV 66 (1%) and HPV 68 (1%), and no participants were infected with HPV genotypes 18, 33, 45. Females, those who have had one or more occasional sexual partner, those who never/rarely/sometimes used condoms during their sexual activity, those with a previous diagnosis of sexually transmitted infection, and those who were not vaccinated were more likely to be tested positive for HPV infection.
Conclusions: The low prevalence of genital HPV infections has provided evidence of the effectiveness of HPV vaccination both in vaccinated and not yet vaccinated subjects through herd immunity and indicated its decisive role in the changing epidemiology of circulating HPV genotypes in the population.
Keywords: HPV vaccination; geno-prevalence; saliva; urine; young adults.
PubMed Disclaimer
Conflict of interest statement
The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Similar articles
- Human Papillomavirus (HPV) Vaccine Effectiveness and Potential Herd Immunity for Reducing Oncogenic Oropharyngeal HPV-16 Prevalence in the United Kingdom: A Cross-sectional Study.
Mehanna H, Bryant TS, Babrah J, Louie K, Bryant JL, Spruce RJ, Batis N, Olaleye O, Jones J, Struijk L, Molijn A, Vorsters A, Rosillon D, Taylor S, D'Souza G. Mehanna H, et al. Clin Infect Dis. 2019 Sep 27;69(8):1296-1302. doi: 10.1093/cid/ciy1081. Clin Infect Dis. 2019. PMID: 30590469 Free PMC article.
- Oral human papillomavirus (HPV) infection and HPV vaccination in an Australian cohort.
de Souza MMA, Hartel G, Olsen CM, Whiteman DC, Antonsson A. de Souza MMA, et al. Int J Cancer. 2023 Jul 15;153(2):417-426. doi: 10.1002/ijc.34517. Epub 2023 Mar 25. Int J Cancer. 2023. PMID: 36943030
- Chlamydia trachomatis infection and HPV/Chlamydia trachomatis co-infection among HPV-vaccinated young women at the beginning of their sexual activity.
Bianchi S, Boveri S, Igidbashian S, Amendola A, Urbinati AM, Frati ER, Bottari F, Colzani D, Landoni F, Tanzi E, Sideri M, Sandri MT. Bianchi S, et al. Arch Gynecol Obstet. 2016 Nov;294(6):1227-1233. doi: 10.1007/s00404-016-4167-x. Epub 2016 Aug 8. Arch Gynecol Obstet. 2016. PMID: 27501926
- An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway.
Enerly E, Flingtorp R, Christiansen IK, Campbell S, Hansen M, Myklebust TÅ, Weiderpass E, Nygård M. Enerly E, et al. PLoS One. 2019 Oct 10;14(10):e0223612. doi: 10.1371/journal.pone.0223612. eCollection 2019. PLoS One. 2019. PMID: 31600341 Free PMC article.
- Universal Human Papillomavirus Vaccination and its Impact on the Southern Italian Region.
Guid M, Bruno A, Tagliaferro L, Aprile V, Tinelli A, Fedele A, Lobreglio G, Menegazzi P, Pasanisi G, Tassi V, Forcina B, Fortunato F, Lupo LI, Zizza A. Guid M, et al. Curr Pharm Des. 2020;26(3):343-357. doi: 10.2174/1381612826666200212115840. Curr Pharm Des. 2020. PMID: 32048956 Review.
References
-
- Dunne E.F., Park I.U. HPV and HPV-associated diseases. Infect. Dis. Clin. N. Am. 2013;27:765–778. doi: 10.1016/j.idc.2013.09.001. - DOI - PubMed
-
- de Martel C., Plummer M., Vignat J., Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int. J. Cancer. 2017;141:664–670. doi: 10.1002/ijc.30716. - DOI - PMC - PubMed
-
- Kombe Kombe A.J., Li B., Zahid A., Mengist H.M., Bounda G.A., Zhou Y., Jin T. Epidemiology and burden of Human Papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation. Front. Public Health. 2021;8:552028. doi: 10.3389/fpubh.2020.552028. - DOI - PMC - PubMed
-
- Pileggi C., Flotta D., Bianco A., Nobile C.G., Pavia M. Is HPV DNA testing specificity comparable to that of cytological testing in primary cervical cancer screening? Results of a meta-analysis of randomized controlled trials. Int. J. Cancer. 2014;135:166–177. doi: 10.1002/ijc.28640. - DOI - PubMed
-
- Lei J., Ploner A., Elfström K.M., Wang J., Roth A., Fang F., Sundström K., Dillner J., Sparén P. HPV Vaccination and the risk of invasive cervical cancer. N. Engl. J. Med. 2020;383:1340–1348. doi: 10.1056/NEJMoa1917338. - DOI - PubMed
RetroSearch is an open source project built by @garambo
| Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3